Scientific paper - Review paper
Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
International Journal of Molecular Sciences, 25 (2024), 3; 1517. https://doi.org/10.3390/ijms25031517

Eržen, Stjepan; Tonin, Gašper; Jurišić Eržen, Dubravka; Klen, Jasna

Cite this document

Eržen, S., Tonin, G., Jurišić Eržen, D. & Klen, J. (2024). Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences, 25. (3). doi: 10.3390/ijms25031517

Eržen, Stjepan, et al. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity." International Journal of Molecular Sciences, vol. 25, no. 3, 2024. https://doi.org/10.3390/ijms25031517

Eržen, Stjepan, Gašper Tonin, Dubravka Jurišić Eržen and Jasna Klen. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity." International Journal of Molecular Sciences 25, no. 3 (2024). https://doi.org/10.3390/ijms25031517

Eržen, S., et al. (2024) 'Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity', International Journal of Molecular Sciences, 25(3). doi: 10.3390/ijms25031517

Eržen S, Tonin G, Jurišić Eržen D, Klen J. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences [Internet]. 2024 January 26 [cited 2024 December 11];25(3). doi: 10.3390/ijms25031517

S. Eržen, G. Tonin, D. Jurišić Eržen and J. Klen, "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity", International Journal of Molecular Sciences, vol. 25, no. 3, January 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:095919. [Accessed: 11 December 2024]

Please login to the repository to save this object to your list.